Lantheus Holdings Inc
NASDAQ:LNTH
Lantheus Holdings Inc
NASDAQ:LNTH
Price:
82.87 USD
4.02%
Market Closed
Updated:
May 21, 2024
Lantheus Holdings Inc
Research & Development
|
Lantheus Holdings Inc
Research & Development Peer Comparison
Comparables:
HAE
COO
XRAY
ALGN
Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Lantheus Holdings Inc
NASDAQ:LNTH
|
Research & Development
-$95.2m
|
CAGR 3-Years
-35%
|
CAGR 5-Years
-40%
|
CAGR 10-Years
-16%
|
|
|
Haemonetics Corp
NYSE:HAE
|
Research & Development
-$53.8m
|
CAGR 3-Years
-20%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-2%
|
|
|
Cooper Companies Inc
NYSE:COO
|
Research & Development
-$145.3m
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
-9%
|
|
|
DENTSPLY SIRONA Inc
NASDAQ:XRAY
|
Research & Development
-$180m
|
CAGR 3-Years
-3%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Align Technology Inc
NASDAQ:ALGN
|
Research & Development
-$351.2m
|
CAGR 3-Years
-23%
|
CAGR 5-Years
-21%
|
CAGR 10-Years
-22%
|
See Also
What is Lantheus Holdings Inc's Research & Development?
Research & Development
-95.2m
USD
-95.2m
USD
Based on the financial report for Mar 31, 2024, Lantheus Holdings Inc's Research & Development amounts to -95.2m USD.
What is Lantheus Holdings Inc's Research & Development growth rate?
Research & Development CAGR 10Y
-16%
-16%
Over the last year, the Research & Development growth was 70%. The average annual Research & Development growth rates for Lantheus Holdings Inc have been -35% over the past three years , -40% over the past five years , and -16% over the past ten years .
You don't have any saved screeners yet
